Reprogramming resistance in advanced lung cancer: epigenetic modulation to restore therapeutic vulnerability.

Saved in:
Bibliographic Details
Title: Reprogramming resistance in advanced lung cancer: epigenetic modulation to restore therapeutic vulnerability.
Authors: He F; Department of Pharmacy, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College), Nanchang, 330029, Jiangxi, China., Moawad MHED; Alexandria Main University Hospital, Alexandria, Egypt.; Faculty of Medicine, Suez Canal University, Ismailia, Egypt., Alsaied MA; Faculty of Medicine, Mansoura University, Mansoura, Egypt., Abdul-Hafez HA; Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine. Hamzaakrm12@gmail.com., Alhadrami HA; Faculty of Applied Medical Sciences, Department of Medical Laboratory Sciences, King Abdulaziz University, P.O. Box 80402, Jeddah, 21589, Kingdom of Saudi Arabia.; King Fahd Medical Research Centre, King Abdulaziz University, P.O. Box 80402, Jeddah, 21589, Kingdom of Saudi Arabia., Azhari AA; Department of Periodontology, Faculty of Dentistry, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia., Nawas BAA; Faculty of Medicine, Mutah University, Al-Karak, Jordan.
Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 Mar 22. Date of Electronic Publication: 2026 Mar 22.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first